APA (7th ed.) Citation

Li, A., Chen, Y., Zhang, W., Zhong, H., Ou, Q., Gu, Y., . . . Yao, H. (2020). Joint association of patients' sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers. Clinical & Translational Medicine, 10(2), 1. https://doi.org/10.1002/ctm2.92

Chicago Style (17th ed.) Citation

Li, Anlin, et al. "Joint Association of Patients' Sex and PD‐L1 Expression with Overall Survival Benefits and Tumor‐immune Microenvironment in Immune Checkpoint Inhibitors for Cancers." Clinical & Translational Medicine 10, no. 2 (2020): 1. https://doi.org/10.1002/ctm2.92.

MLA (9th ed.) Citation

Li, Anlin, et al. "Joint Association of Patients' Sex and PD‐L1 Expression with Overall Survival Benefits and Tumor‐immune Microenvironment in Immune Checkpoint Inhibitors for Cancers." Clinical & Translational Medicine, vol. 10, no. 2, 2020, p. 1, https://doi.org/10.1002/ctm2.92.